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In order to further elucidate the mechanisms by 
which high-dose ultraviolet A1 (UV A1) therapy leads 
to improvement in patients with atopic eczen1.a. we 
assessed skin sections frOin patients before and after 
high-dose UV A1 therapy (n = 5) or conventional 
VVAfUVB therapy (n = 4) for changes in Langerhans 
cells and mast cells expressing the high-affinity IgE 
receptor FceRI and in surface-bound IgE by histo-
chemical and imn1.unohistochemical techniques . The 
twO treatment groups exhibited different patterns of 
changes in the 11.un1.ber ofFceRI+. CD1a+. and mast 
cells within the dermis: The density of both Langer-
hans cells and mast cells was decreased after high-
dose UV A1 therapy. but not after UV AlUVB therapy. 
High-dose UV A1 and UV AlUVB therapy significantly 
increased the 11.umber of CD1a+ cells within the 
T h e fll1ding tl.1at Langcrhans cells (LC), in addition to mast cells, bind IgE through the high-aftinity recep-tor FaR! (Bruynzeel-Koome n ef nl, 1986; Bie ber el n1, 1992; Wang ef nl, 1992; Grabbe ef n1, 1993) prompted speculatio n about the pathophysiologic 
ro le of JgE-bearing LC in atopic eczema. T his hypothesis is based 
on the clinical obse rvation that environmental a ll ergens such as 
house dust mites or pollen can ca use ecze matous skin reactions in 
atopics (Clark and Adinoff, 1989), and on ;/l vitro data concerning 
IgE-mediated antigen prescntation (Mudde ct nl, 1990). In addition, 
mast cells , long known to express FCERI, ha ve also been ide ntified 
as the source of severa l cytokines (Moller and Czarnetzki, 1994), 
suggesting that they are capabl e of modulating immune reac tions in 
the skin upon stimulation by rece ptor-bound IgE after contact with 
allergens. R ecently , it ha s been shown that hig h-dose UVAl 
(340 -400 llIn) treatment improves acute exacerbations of atopic 
eczema more ef!:cctive ly than traditional combine d UVA / UVB 
the rapy (Krutmann et nl, 1992). In order to better understand the 
UV A1 -induced the rape utic effects and the pathophysiology of 
atop ic eczema. we ha ve studied chan ges in FcelU- and IgE-bearing 
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epiderll1.is. but only high-dose UV A1 reduced the 
relative nUll1.ber of IgE+ intraepiderll1.al Langerhans 
cells typically found in atopic ecze11.1.a. Reduction of 
nUll1.bers of derll1.al Langerhans cells and 11.1.ast cells. 
as well as relative nUlnbers of intraepidernlal IgE+ 
Langerhans cells. was closely linked to significant 
clinical ill1.prove11.1.ent by high-dose UV A1. but 11.ot 
UV AIUVB therapy. These studies support the notion 
that IgE-binding cutaneous cells are ill.volved in the 
pathogenesis of atopic eczell1.a. We propose that 
UV A1 radiation exerts its effects in atopic ecze11.1.a, at 
least in part. by inhibiting Langerhans cellll1.igration 
out of the epiderll1.is and. in particular. by reducing 
the nUll1.ber ofIgE-bearing Langerhans cells and ll1.ast 
cells in the derll1.is. Key lVol'ds: Lallgel'halts cells/mast 
cells/FceR!. ] I,,,,est Del'll,atol 107:419-422, 1996 
LC ,U1d mast cells in skin biopsies £i'om patients with atopic eczem a 
b e fore and after UV A1 or UVA/ UVB . 
MATEIUALS AND METHODS 
Patients and Treatment Patients hospitalized fo r acute exacerbation of 
severe atopic eczema werc allocated to trea tment with either high-dose 
UVA 1 (five patients) or conventi.onal UV A/ VVB (four patients) irradia-
ti o n . D eta ils about entrance crite ria and treatment of these patients have 
been published elsewhere (Krutmann cf ai, 1992) . T he two groups were 
well matched dcmographically and clinica lly. ,md their clinical scorcs werc 
comparable (Cos ta cl ai, 1989; Krutmann el ai, 1992). Median serum IgE 
Icvels wcre similar (UVA 1 group: 1084 U / litcr; UVA / VVB group: 1126 
U/ li ter) and did not change signifi cantly under either regimen. After 
informed consCnt, biopsies wcre takcn from elbow f1cxures before therapy 
and after conclusion of trea tment and werc immediately snap-frozcn and 
sto red at - 60°C un ti l processing. The daily dose of UVAI was 130 
joules/cm2, while doscs of UVA/ UVB wcre progressively increased to a 
mean final dose of7 joules UVA /cm 2 and 0.028 joules UVB/cm 2 T he totaJ 
number of treatments was :1 5 fo r each pati ent. 
Staining Procedures and Evaluation C ryos tat sections of biopsies 
were stained wi th toluidine blue at pH 0.5 overnight for metachromasia 
(Schadendorf cf ai, 1995) and by cnzymccytochcl11icalmethods for tryptase 
(Harvima cl ai , 1988) and chloroacetate esterase (CAE) (Sterry and 
Czarnetzki , 1982). Inununohistochcmica.1 sm in ing was p erformed by the 
alb line phospharase-anti-alblinc phosphatase technique as prcviously 
described (Cordell cl ai, 1984). T he fo llowing antibodies were uscd in ti le 
study: monoclonal anti-COl a, reacting with LC (Dako . GloslTup, Dcn-
mark); monoclonal 29C6 against the a -chain of the Fc€IU, which binds in 
the absence as wc ll as in the presence of IgE (Riske /'1 al. 1991) (kindly 
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Table I. High-Dose UV A1 Therapy Reduces Clinical 
Symptoms of Exacerbated Atopic Eczema More 
Effectively than UV AfUVB Treatment 
Treatment R egimcn 
UVA1" 
UVA / UVB' 
C linical Scorc" 
Before T herapy 
63.0 :t 5.8 
56 .3 :t 6.2 
After Therapy 
19.6 :t 5.4 
41.1 ::':: 10.0 
" Costa score po ints (mean .:t SD) obtai lied from patients before and nflcr different 
lypes of UV trCi.ltlllc llt; l O severity cri teri ., and 10 topographic sites were e valuated :md 
sco red frolll 0 (no lesions) to 6 (extremely severe) or 3 (extended lesions). respectively. 
For c:'lch patiCJlt. v;Jlucs were added up to give the tot:" clini cal Score. 
II 11 = 5 palicnts. 
r J1 = 4 patient,'). 
prov ided by J. Hakimi. Nutley, NJ); ;lJ1d polycl onal auti-lgE (Dako). All 
monoclonal an tibod ies were of the IgC1 isotyp". An IgC l anti-de Sill in 
antibody (Dako), w hich stained onl y occasional slI100th muscles (arrecto res 
pilorum). se rved as negative contro l. Sections were eva luated by counting 
nucleated stained cel ls at 1 :400 magnifi cation in at least fiv e adjacent 
microscopic ficlds using a microscopic g rid covering '1 / "16 mm 2 • Staining 
reactions in epidermis, papillary dennis, within inAalllllla to l), infiltrates, 
around skin appendages, and between co llagen fibe rs we re e"amilled 
separately. Counts were expressed as stained ce ll s per lllm2 and norl11ali zed 
to a vaillc o f 1.0 in o rder to ca lcu late changes after treatl1l ent. Differences in 
changes o f IgE+ and CD l a + ep iderl11a l cells observed under each regimen 
arc given as the ratio of l11 ean IgE+ to CD l a + cclls before and after 
thcfilPY· Statistica l ana lys is of changes was performed with the \ Xl ilcoxoll 
matched-pairs signed-ranks test. 
R ES ULTS 
T he clinical response of patients treated with high-dose UVAl w as 
better than that of patients treated with UVA/UVB. Total clinical 
score was reduced to less than one third of pre-treatment va lu es in 
the patients receiving hi gh-dose UV A 1. UV A/UVB treatment 
resu lted in only minor improvem ent, and clinica l response was 
more va riabl e, as is indicated by a greater range of va lues in this 
group (Table I) . 
Sta ining of specimens taken before treatment revea led compara-
ble numbers for C Dl a + and FCER.la+ cell s in the epidermis 
(Table II, Fig la,c) , indicating that most LC expressed the FCEIU , 
whereas 'cell-bound TgE was detectabl e only in abollt half the cells. 
Mast ce lls were absent, because none of the epidermal cells showed 
metachromasia or tryptase o r CAE activity (Fig le). In the dermis, 
the CDla + and tryptase/CAE + cells combin ed approximately 
equalled the number of FCEIU a+ cell s (Table III). N early all of 
these cells also reacted with the anti-.IgE antibody. The density of 
CDI a + cells, in particul ar, and aJso of tryptase/CAE+ cells was 
Table II. Total CD1a +, but Not IgE-Bindillg Epidermal 
CD1a+ Cells Increase Under High-Dose UVA1 Therapy 
of Exacerbated Atopic Eczema 
Marker 
M c ta cilr0 l11HSia i• 
Tryptase" 
C AE" 
CD l a' 
FcEl"t.l ex' 
IgE' 
Cdl Density" 
o 
o 
o 
560 ::':: 277 
458 ::':: 172 
27M :t 24 
C hange" 
UVA1 
2.08 :t 1.24' 
1.35 _ 0.36 
0.92 ::':: 0.38 
UVAlUVB 
3.68 :t 2.52f 
2.85 ::':: 2.7 1.f 
3.41 ::':: 2 .64( 
(/ Mean :t SO o f positive cc l1s/mm2 ill hiopsies from 11 = I) patie nts with acute 
exacerhatio ns of atopi c eczema hefore lrCill"J1)Cnt. Eva Ju:n.ion of LC and mast cc)) 
lHl ll1hcrs was pcrfo nncd b y hi stochc mi c..: al C') and immull o histochemical (') staining . 
• 1 Ntlmhcr.~ before trea tJJ)ent were sct at I .V and ch,w gc." in /lumbers of sta ined 
ccll s/mll12 arc expressed as m ean :t SO of il1 l: rCil SCS o r dccrc:tscs of pre-treatm ent 
"a lues j" " = 5 (UVA I group) ""d " : 4 (UVA / UVI3 grou p) patiell ts. 
" 1' < 11.05. 
I I' < 0.07. 
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Table III. High-Dose UVA1, but Not UVAfUVB, 
Therapy of Atopic Eczema Reduces Both Dermal CD1a+ 
and Mast Cells Binding IgE via FceRI 
C hange" 
Marker Density" UVAI UVA/ UVB 
Metachromasiab 65 ::':: 6 0.3 1 ::t:: 0 .()9'" 0.9 1 :t 0.22 
Tryptase" 141 :t 47 0 .95 :t 0.31 0.92 :t 0.19 
C AE" 173 ::t:: 54 0. 1l6 ::':: 0.22 1.03 ::t:: 0 .13 
CDla' 165 ::t:: 65 0.56 :t 0.13" 3.59 ± 2.0gf 
FCETU cr' 346 ::t:: 12 0.84 :t 0.05" 1.67 :t 0.26f 
IgE' 293 :t 63 0.82 ::t:: 0 .10' 2.16 ::':: 1.37 
" M ea n :t SO of positive ccll s/ t11111 2 in bio psies fru m n :;:::: 9 patie nts w ith :'Icurc 
cX :lccrb"rions of atopic eczema befo re treatll lCllt. Eva lu;ltio ll of LC and mast cell 
numbers was performed by hi stochcmicn l (") :1I1cl immunohistochemical (') stail1ing. 
,/ N umbers he fo re treatment we re sct at 1.0 and chan ges in numbers oC stnincd 
ccl ls/ ml1l2 are expresscd as m can ± SO of in cre:lses o r decreases o f prc-treatlllcm 
va lll cs in 11 ~ 5 (UVA I grollI') alld II = 4 (UVA / UVIJ group) patie l1 ts. 
" p < 0.05. 
f P < 0.07. 
higher in the papillary de rmis than in the reticular dermis, whereas 
metaclu-omasia was greater in the reticular dermis (Table IV) . til 
contrast to the almost equal density of cells with tryptase and CAE 
in the dermi s, metachromatic staining with toluidine blue was 
detected in only a sm all number of cell s. T his discrepancy between 
staining methods , which ha s already been described (Algermissen et 
III, 1994; Markey e/ III, 1989; Haas et III, 1995), was most apparent 
in th e pap illary dermis (Table IV). 
In th e dermis of UVA1-treated skin, both types of cells binding 
IgE via the FCEIU were redu ced . Significant decreases w ere noted , 
in metachro matic cell s and cells expressin g CD1 a as well as minor 
reductions in tryptase+ and CAE+ cells (Table III, Fig H,d, e) . 
Since separate evaluation of cell numbers revealed no significant 
differences of UV A I-ind uced changes be tween vario lls dermal 
compartmen ts (papillary dermis, deeper inflammatory infiltrates, 
around skin appendages, and between collagen fibers) only data 
demonstrating chan ges in th e sta ining pattern of the whole dermis 
are show n. In contrast to the results obtained with UVA1, the 
densi ty of CDl a + , FCEIU a+, and also of IgE + cells , albeit more 
va riably, was enhanced after UVA / UVB treatment (Table ill). 
T hi s effect of UV A/UVB on CD1 a + cell s was even more pro-
noun ced in the reti cular dermi s than in the papillary dermis, 
whereas changes in staining patterns for o ther markers were similar 
in bo th compartments (not shown) . For m ast cells, no effect of 
UVA/UVB could be demonstrated, independent of th eir anatom-
ical distribution (not shown) and the staining m ethods used fo r 
de tection (Table III) . 
After high-dose UV A 1 treatment, biopsy sections ex hibited an 
in crease in CDl a+ epidermal cells (Table II, Fig 1). In contrast. 
no signifi cant increase in the number of cell s bearing FCElUa: or IgE 
Table IV. CDla+ and Mast Cells Equal the FceRIo+ 
IgE-Binding Cells in Papillary and Reticular Dermis o f 
Atopic Eczema 
Marker Papillary Dermis R.eticular D ennis 
Mctachrornas i;l" 43 ::':: 9 75 :t 9 
Tryptasc" 182 :t 42 122 :t 43 
CAE" 227 ::':: 64 1 54 :t 49 
CD la' 46 1 :t 218 66 :t 19 
FCER.lc{ 528 ::':: 204 2118 ::':: 77 
IgE' 576 :t 189 195 :t 4 1 
" Ev'llu;)riull of LC and 111:t.'it cdl 1I111nhcni was pc rfilrl11cd h y histoche mica l ('I) and 
i1l11H1In obi~toch c mical ('') staining, of skin biops'ies fro 111 nine pati ents. C ell density i 
expressed as mean :t: SD o f lIumbe rs or posidvc celis/nllll ! , (Posit ive cells within 
deeper inlbl1l1n atory infiltra tes. aro und skill appenda ges, and betweell co ll agen fIbe r! 
were added up giving, tile ;Ivcrage Ilumhers of re acti ve ce lls ill the retic ular dennis.) 
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Figure 1. Density of FCERI-bearing LC and mast cells changes under high-dose UV Ai therapy of exacerbated atopic eczema. 
Immunohistochemical sta ining (a lka linc phosphatase-anti- alkalinc phosphatase system) for C01 a (a,ll) and FceRla (r,d) and enzyme Itistochemistry for CAE 
(eJ) of biops ies fi'om lesions of one patient with atopic eczema taken before (a,r,e) and after (b,dJ) treatment with high-dose UVAl (sralt bar. 10.0 J..Lm). 
could be observed (Fig lt1). After UYA/UVB th 'rapy, numbers of 
LC were also increased, but UYA /UVB and high-dose UY Al 
produced d ifferent results in relation to the other markers. T here 
was a marked increase also in the number both of FcelUa+ and 
19E+ ce ll s after UYA/UYB (Table II) . T hus, despite the increase 
in absolute numbers ofCDla + ep iderma l cell s, the ratio ofTgE+ to 
COla+ cells decreased in the UYAl group by a fa ctOl' of 0.5 . 
whereas it remained nearly constant with minimal change by a 
factor of 0.94 in the UYA/ UYB group. 
D ISCUSS ION 
Our data indicate that UYAl radia tion leads to th l'l:e major changes 
in IgE-bearing cells in the skin of atopi c eczema patients: (i) 
decrease in m etachromati c and COl a + as well as FCEIUa + and 
IgE+ cells in the dennis, (ii) accu mulation of COl a+ cells, i.e., LC. 
in the epidermal compartment. (iii) concomitant r 'duction of 
FceRJa+ and 19E+ epidermal LC. 
UYAJ therapy and VV A/VVB therapy differed markedly with 
rega rd to their effects on both mast cells and CO l a + cells in the 
dermis. T he number of toluidine blue-stained cells in the dennis 
was decrea~ed in UYA 1-ilTadiated. but not in UY A/ UYB-treated 
pati ents. Om findings are in agreement with studi es of psoralen plus 
UV A-treated patients with cutaneous mastocytosis showing a re-
duction in numbers of dermal mast cell s (Granel'Us e ( nl, 1981; 
Kolde c( nl, 1984). R ecent observations suggest that in addition to 
psoralen p lus UYA. high-dose UYA I radia tion therapy may be 
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effective in the treatment of patients with cutaneous mastocytosis 
(Stege et ai, 1996) . Taken together, these studies indicate that 
dermaJ mast cells represent target cells in high-dose UVAl therapy. 
T he lack of effect on dermal mast cells after UV A/UVB treatment 
may be explained by its physical properties: th e UVB portion of the 
emission spectrum is almost completely absorbed by the epidermal 
layers, and the UV A dose reaching the dermis is relatively low as 
compared to that from high-dose UVAl radiation. T he most 
striking difference between the two treatments was in the density of 
COla + dendritic cells in the dermis. A significantly reduced 
number of COla+ dendl;tic cells was observed only after UVAl 
treatment, whereas UV A/UVB therapy led to an increase in tbese 
cells. Again, these differences may be attributable to the different 
physical properties of UV A 1 /Jemls UV A/UVB radiation. 
Accumulation of COla + cells in the epidermal compartment is 
in agreement with previous studies in which C01.a+ and COlc+ 
epidermal cells were found to be increased after UV Al treatment, 
whereas MHC class II + or IgE-reactive cells were 11 0t. I Photother-
apy-induced intraepidermal accumulation of LC m ay be caused by 
UV-induced immobilization of these cells within the epidermal 
compartment, which may re fl ect an antiinflammatory effect tbat 
prevents their interaction with dermal T cells. UV-inducible cyto-
kiJles may acco unt fo r this finding (Streilein, 1995). An increase in 
LC was also observed in patients undergoin g UV A/ UVB treat-
ment. T here was a marked difference, however, between tbe effects 
of the two treatments on the number of IgE+ cells: with UVA 1 
treatment, the density of FCERl a+ and IgE+ cells was barely 
affected, and thus the relative Ilumber oflgE-bearing LC decreased, 
while UV A/UVE th erapy led to increased numbers of these cells. 
T hese different patterns were associated with different o utcomes: 
clinical improvement in UVA1-treated patients and lack of signif-
icant improvement in UVA/UVB-treated pati ents. T h e fact that 
the nurnber of epidermal cells expressing FcElUa and bearing IgE 
was not increased in UVA1-treated skin, despite upregulation of 
COl a + cells, may indicate functional changes affecting the expres-
sion of IgE-binding si tes in these cells. Our fmdings support the 
assumption that binding oflgE molecules by LC is of pathogenetic 
importance fo r the induction and maintenance of atopic eczema 
(Clark and Adino/f, 1989; Mudde e( ai, 1990). 
Possible mechanisms underlying the clinical improvement of 
atopic eczema after high-dose UV At treatm ent include inhibitory 
e ffe cts on the expression of the adhesion molecule ICAM-l, 
decreased numbers of infiltrating helper T cells, and, in particular, 
reduced ill silll expression of the proillflammatory cytokine in.ter-
feron-/, and induction of the antiinflamm atory, ke ratinocyte-de-
rived cytokine interleukin-l0 (Krutmann and Trefzer, 1992; Grewe 
et ai, 1994, 1995). Comparing the histologic changes i.n our 
patients, we conclude that high-dose UVAl radiation may also 
exert its therapeuti c effects by modulating the number and probably 
function of FCERl-bearing LC in the skin. In addition, changes in 
the number and possibly also the functional status of dermal mast 
cells may contribute to th e clini cal effects of the treatments. 
Add itional studies w ill be needed to clarify whether the observed 
changes are specific for high-dose UV A 1 radiation or may also be 
obse rved in healing of atopic eczema, eithe r by spontaneous 
improvement o r in response to other kinds of treatment. 
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